Portable MRI achieves 'immense success' in study of critically ill children

Results from the world’s first study on the use of portable MRI equipment during pediatric ECMO therapy were published April 4 in Critical Care.

Extracorporeal membrane oxygenation (ECMO) procedures oxygenate blood from outside of the body, which requires specialized equipment. These patients are typically critically ill and are monitored via numerous pieces of medical equipment that are not easily transported for imaging necessary to monitor patients' responses to treatment. This is especially true in pediatric patients undergoing ECMO therapy, as access to patients’ blood usually occurs through the neck, making transportation a delicate and sometimes impossible process.

Neuroimaging during modern intensive care medicine often remains a challenge. Especially in pediatric patients, easily accessible availability of high-quality brain imaging remains an often unbeatable hurdle,” corresponding author of the new paper Hemmen Sabir, from the Department of Neonatology and Pediatric Intensive Care at Bonn University Hospital (UKB) in Germany, and colleagues explained.

Sabir explained that there is a need to monitor certain brain structures during ECMO therapy, and that other imaging modalities, such as ultrasound and CT, have their own limitations and pitfalls. In recent years, low-field portable MRI equipment has emerged as a potential solution to such conundrums, but until recently its utility in bedside pediatric ECMO settings had not been tested.

A team at UKB was able to test the feasibility of portable MRI exams on four patients at the facility who were undergoing ECMO therapy. The patients ranged in age from a newborn baby to a 10-year-old child. Exams were successfully and safely completed on each child, with one being sent for immediate treatment after a large brain hemorrhage was identified on their imaging.

Prof. Andreas Müller, director of the Department of Neonatology at UKB, described the team’s work as an “immense success.”

"The new findings prove that the scan can be performed safely. We obtained meaningful MRI images of the brain without changing the position of the neck cannula and without compromising the children's safety status,” Müller said. “This represents an immense success for future MRI examinations of newborns and larger children who can only survive through the use of ECMO therapy.”

Since obtaining the portable MRI equipment via funding received from a grant from the Bill Gates Foundation, the hospital has utilized the machine in dozens of children. It has helped to identify numerous urgent findings, such as brain hemorrhages, strokes, acute accumulation of cerebrospinal fluid, etc. While experts maintain that conventional MRI still offers superior image quality, portable MRI is ideal for emergency diagnostics, they suggested.

The study is available to view here.

Hannah murhphy headshot

In addition to her background in journalism, Hannah also has patient-facing experience in clinical settings, having spent more than 12 years working as a registered rad tech. She joined Innovate Healthcare in 2021 and has since put her unique expertise to use in her editorial role with Health Imaging.

Around the web

The newly approved PET radiotracer is expected to improve patient care significantly. “We have been able to reach the pinnacle of myocardial perfusion imaging with flurpiridaz," one expert said.

GE HealthCare's flurpiridaz, the PET radiotracer that recently received FDA approval, offers several key benefits over SPECT. Jamshid Maddahi, MD, discussed the details in an exclusive interview. 

Ultrafast MCE could go on to become a go-to treatment option for obstructive coronary artery disease, according to the authors of a new first-in-human clinical study.

Trimed Popup
Trimed Popup